| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00427428 |
| P698 | PubMed publication ID | 6429705 |
| P2093 | author name string | D K Hatsukami | |
| J R Hughes | |||
| R W Pickens | |||
| S Malin | |||
| A Luknic | |||
| D Krahn | |||
| P2860 | cites work | Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment | Q34057373 |
| Pharmacological and psychological determinants of smoking. A New York University honors program lecture | Q39177904 | ||
| Cigarette Smoking: A Dependence on High-Nicotine Boli | Q39221877 | ||
| The nature and determinants of adjunctive behavior | Q40016228 | ||
| Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia | Q40024689 | ||
| The double-blind in danger: untoward consequences of informed consent | Q42256804 | ||
| Mazindol: Its efficacy and mode of action in generating weight loss | Q47312048 | ||
| Clinical use of nicotine chewing-gum. | Q55095869 | ||
| The use of nicotine gum during cessation of smoking | Q67554305 | ||
| Increasing the validity of self-reports of smoking behavior in children | Q67600333 | ||
| Changes in behavioral and physiological activation induced by cigarette smoking in habitual smokers | Q69406717 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nicotine | Q12144 |
| P304 | page(s) | 82-87 | |
| P577 | publication date | 1984-01-01 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Effect of nicotine on the tobacco withdrawal syndrome | |
| P478 | volume | 83 |
| Q89729207 | "I cannot live without my vape": Electronic cigarette user-identified indicators of vaping dependence |
| Q33886815 | A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats |
| Q37030113 | A placebo-controlled trial of modafinil for nicotine dependence |
| Q42592357 | A smoking cessation intervention program for family physicians. |
| Q36983140 | Age-related differences in working memory deficits during nicotine withdrawal |
| Q37341565 | Association of abstinence-induced alterations in working memory function and COMT genotype in smokers |
| Q36492892 | Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation |
| Q41716586 | Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers |
| Q38954406 | Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model |
| Q35207903 | Clinical considerations in study designs that use cotinine as a biomarker |
| Q34183988 | Cognitive enhancers in the treatment of substance use disorders: clinical evidence |
| Q48789041 | Community patterns of transdermal nicotine use and provider counseling |
| Q34197589 | Contingent payment procedures for smoking reduction and cessation |
| Q69366999 | Controlled trial of transdermal nicotine patch in tobacco withdrawal |
| Q39767712 | Craving for cigarettes |
| Q58270412 | Craving: A Problematic Concept in Smoking Research |
| Q43237128 | Does nicotine chewing gum work? |
| Q36677397 | Dopamine D3 receptor ligands for the treatment of tobacco dependence |
| Q41681631 | Dose effects of nicotine gum |
| Q37497959 | Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype |
| Q72521587 | Effect of smoking cessation and relapse on cardiovascular levels and reactivity |
| Q46701762 | Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. |
| Q72579679 | Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms |
| Q37179878 | Effects of 7.5% carbon dioxide inhalation on anxiety and mood in cigarette smokers |
| Q52001787 | Effects of a 2-day abstinence from smoking on dietary, cognitive, subjective, and physiologic parameters among younger and older female smokers. |
| Q30484567 | Effects of cigarette smoking and abstinence on Stroop task performance |
| Q36083478 | Effects of continuous nicotine treatment and subsequent termination on cocaine versus food choice in male rhesus monkeys. |
| Q48913424 | Effects of nicotine gum on prevalence and severity of withdrawal in female cigarette smokers |
| Q37203879 | Effects of nicotine in experimental animals and humans: an update on addictive properties |
| Q48851439 | Effects of nicotine on hunger and eating in male and female smokers |
| Q35953708 | Effects of tobacco smoking on caloric intake |
| Q37650592 | Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study |
| Q37490177 | Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers |
| Q40609073 | Effects of tryptophan depletion on acute smoking abstinence symptoms and the acute smoking response |
| Q93664321 | Effects of withdrawal from long-term nicotine gum use |
| Q50143766 | Environmental Determinants of the Reinforcing Effects of Nicotine in Humans |
| Q47644733 | Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients |
| Q36425005 | Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India |
| Q64916306 | Factors Associated with Adherence to Transdermal Nicotine Patches within a Smoking Cessation Effectiveness Trial. |
| Q68339007 | Failure to support the validity of the fagerstrom tolerance questionnaire as a measure of physiological tolerance to nicotine |
| Q37596813 | Future trends in the pharmacological treatment of smoking cessation |
| Q34674170 | Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General |
| Q74660407 | Heart rate variability during the first month of smoking cessation |
| Q47560544 | Helping Smokers Quit: The Smoking Cessation Leadership Center Engages Behavioral Health by Challenging Old Myths and Traditions |
| Q52238616 | Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum. |
| Q34033200 | Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society |
| Q51133250 | Individual differences in stress and arousal during cigarette smoking. |
| Q37206730 | Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking |
| Q33566228 | Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal |
| Q52295725 | Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures? |
| Q33897781 | Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function |
| Q55620817 | Letter from Chicago: Dog days. |
| Q38674138 | Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire |
| Q41066875 | Measuring tobacco withdrawal: a review of self-report questionnaires |
| Q44049031 | Mediating mechanisms for the impact of bupropion in smoking cessation treatment |
| Q36257654 | Medication screening for smoking cessation: a proposal for new methodologies |
| Q44099974 | Mood differences between male and female light smokers and nonsmokers |
| Q48616530 | Moxonidine versus placebo as an aid in smoking cessation |
| Q57477286 | Nasal Nicotine Solution as an Aid to Cigarette Withdrawal: a pilot clinical trial |
| Q35946885 | Negative mood reverses devaluation of goal-directed drug-seeking favouring an incentive learning account of drug dependence |
| Q36298171 | Neural substrates of abstinence-induced cigarette cravings in chronic smokers |
| Q35164053 | Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories |
| Q34346581 | Neurobiological mechanisms of nicotine craving |
| Q46744251 | Nicotine addiction: past, present and future. Marian Fischman lecture given at the 2007 meeting of CPDD. |
| Q39595749 | Nicotine and smoking: a perspective from animal studies |
| Q37718442 | Nicotine as a psychoactive drug |
| Q36277268 | Nicotine as a typical drug of abuse in experimental animals and humans. |
| Q52213167 | Nicotine modulates effects of stress on acoustic startle reflexes in rats: dependence on dose, stressor and initial reactivity. |
| Q72579725 | Nicotine or tar titration in cigarette smoking behavior? |
| Q46188222 | Nicotine polacrilex: clinic-based strategies with chronically ill smokers |
| Q40485708 | Nicotine replacement therapy. What has been accomplished--can we do better? |
| Q48950230 | Nicotine replacement: ten-week effects on tobacco withdrawal symptoms |
| Q40824648 | Nicotine transdermal systems |
| Q57269167 | Nicotine withdrawal in women |
| Q43719675 | Nicotine, alcohol, methamphetamine, and inhalant dependence: a comparison of clinical features with the use of a new clinical evaluation form |
| Q68626529 | Nicotine-replacement therapy with use of a transdermal nicotine patch--a randomized double-blind placebo-controlled trial |
| Q43150610 | Nicotine. Influence on sleep and its relevance for psychiatry and psychotherapy |
| Q37206584 | Nicotinic receptor blockade therapy and smoking cessation |
| Q34376892 | Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems |
| Q38375230 | Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability |
| Q44638852 | Pharmacologic and sensorimotor components of satiation in cigarette smoking |
| Q57477367 | Plasma Nicotine Concentrations from Repeated Doses of Nasal Nicotine Solution |
| Q90439301 | Possible New Symptoms of Tobacco Withdrawal III: Reduced Positive Affect-A Review and Meta-analysis |
| Q30481574 | Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats |
| Q44090137 | Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms |
| Q48807248 | Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program |
| Q48953080 | Processes of change in heavy and light smokers |
| Q40890337 | Psychostimulant Abuse: The Case for Combined Behavioral and Pharmacological Treatments |
| Q44957144 | Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. |
| Q48922350 | Reasons for smoking and severity of residual nicotine withdrawal symptoms when using nicotine chewing gum. |
| Q35629753 | Resilient but addicted: The impact of resilience on the relationship between smoking withdrawal and PTSD. |
| Q46670494 | Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials |
| Q43661378 | Self-reported abstinence effects in the first month after smoking cessation |
| Q67837227 | Signs and symptoms from nicotine gum abstinence |
| Q38758931 | Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? |
| Q92993098 | Sleep quality in cigarette smokers and nonsmokers: findings from the general population in central China |
| Q67752153 | Smokeless tobacco abstinence effects and nicotine gum dose |
| Q33890752 | Smoking cessation. Techniques and benefits |
| Q68131515 | Smoking cessation: treatment options and the pharmacist's role |
| Q24202028 | Strategies to improve retention in randomised trials |
| Q48856341 | Stress and arousal in sedative and stimulant cigarette smokers |
| Q51126112 | Subjective and behavioural evaluation of cigarette cravings. |
| Q36708864 | Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch |
| Q29042351 | The addiction Stroop task: examining the fast and slow effects of smoking and marijuana-related cues |
| Q36599309 | The coupling of nicotine and stimulant craving during treatment for stimulant dependence |
| Q39506506 | The development and initial validation of a questionnaire on smoking urges |
| Q47320722 | The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain |
| Q41380346 | The effects of nicotine chewing gum on the sensitivity to muscle tension |
| Q41559912 | The role of nicotine in smoking: a dual-reinforcement model. |
| Q40510452 | The scientific case that nicotine is addictive. |
| Q49093143 | Tobacco withdrawal symptoms: an experimental analysis |
| Q41299949 | Training physicians about smoking cessation: a controlled trial in private practice |
| Q69426466 | Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study |
| Q34715360 | Treatment of tobacco dependence: integrating recent progress into practice |
| Q35782141 | Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial |
| Q30483957 | Varenicline improves mood and cognition during smoking abstinence |
| Q39546004 | Which smokers report most relief from craving when using nicotine chewing gum? |
| Q80467421 | [In-patient smoker? - Providing appropriate intervention] |
| Q69552658 | [Smoking cessation, but how?] |
Search more.